Literature DB >> 31272829

Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD.

Mark Y Fang1, Sebastian Markmiller1, Anthony Q Vu1, Ashkan Javaherian2, William E Dowdle3, Philippe Jolivet4, Paul J Bushway5, Nicholas A Castello2, Ashmita Baral2, Michelle Y Chan2, Jeremy W Linsley2, Drew Linsley6, Mark Mercola5, Steven Finkbeiner7, Eric Lecuyer8, Joseph W Lewcock3, Gene W Yeo9.   

Abstract

Stress granules (SGs) form during cellular stress and are implicated in neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). To yield insights into the role of SGs in pathophysiology, we performed a high-content screen to identify small molecules that alter SG properties in proliferative cells and human iPSC-derived motor neurons (iPS-MNs). One major class of active molecules contained extended planar aromatic moieties, suggesting a potential to intercalate in nucleic acids. Accordingly, we show that several hit compounds can prevent the RNA-dependent recruitment of the ALS-associated RNA-binding proteins (RBPs) TDP-43, FUS, and HNRNPA2B1 into SGs. We further demonstrate that transient SG formation contributes to persistent accumulation of TDP-43 into cytoplasmic puncta and that our hit compounds can reduce this accumulation in iPS-MNs from ALS patients. We propose that compounds with planar moieties represent a promising starting point to develop small-molecule therapeutics for treating ALS/FTD.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS-FTD; TDP-43; high-content screening; motor neurons; planar molecule; stress granule

Mesh:

Substances:

Year:  2019        PMID: 31272829      PMCID: PMC6728177          DOI: 10.1016/j.neuron.2019.05.048

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  76 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Improved statistical methods for hit selection in high-throughput screening.

Authors:  Christine Brideau; Bert Gunter; Bill Pikounis; Andy Liaw
Journal:  J Biomol Screen       Date:  2003-12

3.  Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.

Authors:  C Korth; B C May; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis.

Authors:  Manal A Farg; Kai Y Soo; Sadaf T Warraich; Vinod Sundaramoorthy; Ian P Blair; Julie D Atkin
Journal:  Hum Mol Genet       Date:  2012-11-19       Impact factor: 6.150

5.  The Stress Granule Transcriptome Reveals Principles of mRNA Accumulation in Stress Granules.

Authors:  Anthony Khong; Tyler Matheny; Saumya Jain; Sarah F Mitchell; Joshua R Wheeler; Roy Parker
Journal:  Mol Cell       Date:  2017-11-09       Impact factor: 17.970

6.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

7.  Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS.

Authors:  Florian Krach; Ranjan Batra; Emily C Wheeler; Anthony Q Vu; Ruth Wang; Kasey Hutt; Stuart J Rabin; Michael W Baughn; Ryan T Libby; Sandra Diaz-Garcia; Jennifer Stauffer; Elaine Pirie; Shahram Saberi; Maria Rodriguez; Assael A Madrigal; Zacharias Kohl; Beate Winner; Gene W Yeo; John Ravits
Journal:  Acta Neuropathol       Date:  2018-06-07       Impact factor: 17.088

Review 8.  Principles for targeting RNA with drug-like small molecules.

Authors:  Katherine Deigan Warner; Christine E Hajdin; Kevin M Weeks
Journal:  Nat Rev Drug Discov       Date:  2018-07-06       Impact factor: 84.694

9.  Pyrvinium pamoate changes alternative splicing of the serotonin receptor 2C by influencing its RNA structure.

Authors:  Manli Shen; Stanislav Bellaousov; Michael Hiller; Pierre de La Grange; Trevor P Creamer; Orit Malina; Ruth Sperling; David H Mathews; Peter Stoilov; Stefan Stamm
Journal:  Nucleic Acids Res       Date:  2013-02-07       Impact factor: 16.971

10.  RNA phase transitions in repeat expansion disorders.

Authors:  Ankur Jain; Ronald D Vale
Journal:  Nature       Date:  2017-05-31       Impact factor: 49.962

View more
  51 in total

Review 1.  Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.

Authors:  Mathieu Bartoletti; Daryl A Bosco; Sandrine Da Cruz; Clotilde Lagier-Tourenne; Nicole Liachko; Sebastian Markmiller; Kristin M Webster; Kristi A Wharton
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

Review 2.  DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases.

Authors:  Nidheesh Thadathil; Roderick Hori; Jianfeng Xiao; Mohammad Moshahid Khan
Journal:  Chromosome Res       Date:  2019-11-09       Impact factor: 5.239

Review 3.  Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Authors:  Han-Jou Chen; Jacqueline C Mitchell
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

Review 4.  Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.

Authors:  Elisa Giacomelli; Björn F Vahsen; Elizabeth L Calder; Yinyan Xu; Jakub Scaber; Elizabeth Gray; Ruxandra Dafinca; Kevin Talbot; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

5.  Competing Protein-RNA Interaction Networks Control Multiphase Intracellular Organization.

Authors:  David W Sanders; Nancy Kedersha; Daniel S W Lee; Amy R Strom; Victoria Drake; Joshua A Riback; Dan Bracha; Jorine M Eeftens; Allana Iwanicki; Alicia Wang; Ming-Tzo Wei; Gena Whitney; Shawn M Lyons; Paul Anderson; William M Jacobs; Pavel Ivanov; Clifford P Brangwynne
Journal:  Cell       Date:  2020-04-16       Impact factor: 41.582

Review 6.  The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future.

Authors:  Heike J Wobst; Korrie L Mack; Dean G Brown; Nicholas J Brandon; James Shorter
Journal:  Med Res Rev       Date:  2020-02-11       Impact factor: 12.944

7.  Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization.

Authors:  Isabella I Sanchez; Thai B Nguyen; Whitney E England; Ryan G Lim; Anthony Q Vu; Ricardo Miramontes; Lauren M Byrne; Sebastian Markmiller; Alice L Lau; Iliana Orellana; Maurice A Curtis; Richard Lewis Maxwell Faull; Gene W Yeo; Christie D Fowler; Jack C Reidling; Edward J Wild; Robert C Spitale; Leslie M Thompson
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

Review 8.  FUS and TDP-43 Phases in Health and Disease.

Authors:  Bede Portz; Bo Lim Lee; James Shorter
Journal:  Trends Biochem Sci       Date:  2021-01-11       Impact factor: 13.807

9.  Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins.

Authors:  Emanuele Buratti
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.

Authors:  Alistair Wood; Yuval Gurfinkel; Nicole Polain; Wesley Lamont; Sarah Lyn Rea
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.